Leptin Regulation of Bone Metabolism and Mineral Density

Leptin, an adipocyte-derived hormone, exerts pivotal control over skeletal homeostasis by integrating energy reserve signals with bone remodelling. It modulates the differentiation and activity of osteoblasts and osteoclasts through both central pathways in the hypothalamus and peripheral signalling in bone marrow. Central leptin action influences sympathetic tone and neuroendocrine factors, thereby indirectly adjusting bone formation and resorption. Peripherally, leptin receptors on mesenchymal stem cells and stromal lineages steer the balance between adipogenesis and osteogenesis, impacting bone marrow adipose tissue content and trabecular architecture. Circulating leptin levels correlate with bone mineral density (BMD) in clinical cohorts, reflecting its dual role: at physiological concentrations it can promote osteoblastic activity, whereas excess leptin in obesity may foster low-grade inflammation that compromises bone quality. Genetic ablation or receptor deficiency in rodent models has revealed complex outcomes, with leptin signalling necessary for adaptive responses to mechanical loading and for preventing marrow adipose expansion. Collectively, these findings underscore leptin as an endocrine nexus linking nutritional status, fat mass, and skeletal integrity, with broad implications for treating osteoporosis and metabolic bone diseases.

Research from Nature Portfolio

Recent studies in human cohorts and animal models have refined our understanding of leptin’s skeletal influence. In a large community-dwelling cohort of older adults, fat mass index and mechanical loading were dissociated to reveal that higher leptin concentrations independently predict both bone mineral content and density, highlighting leptin as a key adipokine determinant of bone mass beyond weight-bearing effects. Sex-specific interactions were identified, with leptin exerting stronger associations in women and in individuals with elevated inflammatory markers. In parallel, a murine investigation of weight-bearing deprivation compared wild-type and leptin-deficient ob/ob mice subjected to hindlimb unloading. Leptin deficiency did not attenuate unloading-induced osteopenia, demonstrating that central leptin signalling is not required for disuse-related bone loss but is essential for normal cancellous architecture and mechanical adaptation.

Leptin Regulation of Bone Metabolism and Mineral Density publication trend

The graph below shows the total number of articles in leptin regulation of bone metabolism and mineral density across all publications each year (not limited to Nature Index journals).

Technical terms

Leptin: An adipocyte-derived hormone that signals energy sufficiency and regulates bone remodelling via central and peripheral receptors.

Adipokine: A bioactive protein secreted by adipose tissue that influences metabolic, inflammatory and skeletal processes.

Osteoblast: A bone-forming cell responsible for synthesising bone matrix and facilitating mineral deposition.

Osteoclast: A bone-resorbing cell that degrades mineralised matrix during bone remodelling.

Bone mineral density (BMD): A measure of mineral content per unit bone area, indicating bone strength and fracture risk.

Bone marrow adipose tissue (MAT): Fatty deposits within the marrow cavity, inversely related to osteogenesis.

Mesenchymal stem cell (MSC): A multipotent progenitor in bone marrow that differentiates into osteoblasts, adipocytes or chondrocytes.

MicroRNA: A small non-coding RNA that regulates gene expression post-transcriptionally, affecting cellular differentiation.

References

1. Determinants of bone mass in older adults with normal- and overweight derived from the crosstalk with muscle and adipose tissue. Scientific Reports (2023).
2. Effect of Leptin Deficiency on the Skeletal Response to Hindlimb Unloading in Adult Male Mice. Scientific Reports (2019).
3. Hypothalamic Leptin Gene Therapy Reduces Bone Marrow Adiposity in ob/ob Mice Fed Regular and High-Fat Diets. Frontiers in Endocrinology (2016).
4. MicroRNA miR-874-3p inhibits osteoporosis by targeting leptin (LEP). Bioengineered (2021).
5. Increased Serum Leptin Level Predicts Bone Mineral Density in Hemodialysis Patients. International Journal of Endocrinology (2020).
6. Obesity and Bone Health: A Complex Link. Frontiers in Cell and Developmental Biology (2020).